Cooling inflation in Australia keeps the possibility of further rate hikes alive, which keeps investors focused on companies where earnings growth does not rely on cheap money. That is where the Healthy high growth potential screener comes in. It surfaces stocks that analysts expect to grow earnings strongly while maintaining sound balance sheets. This article highlights three screened stocks that offer a structured way to target that potential growth.
The stocks covered below are just a starting sample, with the full screen surfacing 55 more companies that analysts expect to deliver strong earnings growth while keeping their financial footing in check. Head straight into the Healthy high growth potential screener to identify, filter and analyze the highest conviction ideas for your watchlist.
Overview: Kraken Robotics is a marine technology company that supplies Synthetic Aperture Sonar systems, KATFISH towed SAS survey solutions and related underwater sensors and batteries for defense and offshore energy customers. These SAS and towed survey contracts align with the Healthy high growth potential theme. Alongside this, Kraken also provides LiDAR, sub bottom imaging and other underwater robotic equipment for military and commercial projects across global markets.
Operations: Kraken Robotics generates about CA$66 million from Products and CA$41 million from Services, with revenue primarily coming from the Asia Pacific region at about CA$57 million, followed by North America at about CA$26 million and EMEA at about CA$20 million.
Market Cap: CA$1.77 billion
Kraken Robotics provides exposure to advanced underwater imaging and mapping, where SAS and KATFISH towed survey contracts are tied to long term defense and offshore projects. The company reports a busy order book in 2026, supported by defense, offshore energy and ocean science customers, and the Covelya acquisition broadens its sonar and navigation offering. At the same time, Kraken is still working through losses, relies on sizeable contracts and uses external borrowing, so execution, contract timing and balance sheet discipline remain important considerations. For investors who want growth tied directly to subsea defense and offshore activity, this mix of potential and risk may make Kraken worth a closer look.
Kraken Robotics’ busy 2026 order book and subsea defense exposure could be only half the story. Get the full context on contracts, balance sheet pressure and execution risk in the analysis report for Kraken Robotics
Overview: Cameco is a Canadian nuclear fuel company that supplies uranium and related services to power utilities worldwide, with its Uranium segment exploring, mining, milling, purchasing and selling uranium concentrate that feeds nuclear reactors. While it also earns revenue from Fuel Services and its 49% stake in Westinghouse, the core link to the Healthy high growth potential theme is this uranium production, which is tied directly to expectations for multi year growth in nuclear generated electricity and fuel demand.
Operations: Cameco generates about CA$2.9b from Uranium, CA$3.4b from Westinghouse, around CA$551 million from Fuel Services and a small CA$3 million from Other activities.
Market Cap: CA$61.7b
Cameco may appeal to investors seeking exposure to the nuclear fuel chain, with its uranium mining segment directly linked to anticipated growth in nuclear power and a 49% stake in Westinghouse adding reactor technology and services on top. Analysts forecast earnings growth of about 35.3% a year over the next 3 years and a high future ROE of 28.7%. However, this growth story comes with trade offs, including a rich P/S multiple, recent margin pressure and a funding model that leans on external borrowing. Project delays, contracting cycles and operational issues at assets like McArthur River are also important considerations. Evaluating how this growth potential compares with these risks is central to assessing the opportunity.
Accelerating interest in nuclear fuel and Cameco’s mix of uranium production with Westinghouse exposure leaves a key question: How well does the growth story stack up against execution and funding risks in the analyst forecasts for Cameco
Overview: Celestica provides design, manufacturing and end to end supply chain services for hardware used by original equipment makers and cloud based service providers around the world. Its strongest link to the Healthy high growth potential theme is the Connectivity and Cloud Solutions segment, where Celestica builds rack scale data center and AI infrastructure for hyperscalers, including the Helios AI platform developed with AMD.
Operations: Celestica generates about US$12.3b from Connectivity & Cloud Solutions and around US$3.3b from Advanced Technology Solutions.
Market Cap: CA$46.8b
Celestica catches the eye because its Connectivity and Cloud Solutions business plugs directly into rising demand for AI and data center hardware from hyperscalers, while analysts still see solid earnings growth and a healthy balance sheet. Forecasts for strong revenue and earnings expansion, a projected 36% ROE and improving profit margins point to a business that is turning this AI exposure into profitability rather than just headline hype. The trade off is meaningful reliance on a handful of large cloud customers and on keeping complex technology ramps like 800G and future 1.6T programs on track, which can make results more volatile. For investors willing to accept that concentration risk, the combination of growth, cash generation potential and AI infrastructure exposure may be worth a deeper look.
Celestica’s AI hardware momentum is hard to ignore; however, heavy reliance on a few hyperscalers leaves an important question about the durability of that growth path that the analyst forecasts for Celestica starts to answer
Fresh opportunities can move from quiet to flying quickly. Use these curated stock lists while they are still under the radar for now. The window can drop fast, act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com